Director of Business Development

We’re partnering with a fast-emerging regulatory consulting firm who are looking for a business development director with a hunter minded mentality to lead commercial growth while delivering high-impact client solutions across pharma, biotech, and medical device sectors.

Sales Leadership & Strategic Selling

• FSP Model Expertise: Proven ability to sell Functional Service Provider (FSP) models to pharmaceutical and biotech clients.
• New Business Development: Proactive, hunter-style sales approach focused on opening new accounts and driving deal flow.
• Enterprise Client Engagement: Demonstrated success in initiating relationships and securing meetings with senior leaders at top global pharma companies.

Professional Traits & Work Ethic

• Ownership Mentality: Operates with an entrepreneurial mindset, taking full ownership of growth and success.
• Driven & Resilient: Self-motivated and persistent, with the stamina to build market presence in a competitive environment.
• Unrestricted Engagement: No active non-compete or NDA that would prevent participation in pharma or regulatory business development.

Industry & Service Line Expertise

• Regulatory Affairs Insight: Strong grasp of regulatory consulting services, especially in the post-approval space.
• CMC Services Knowledge: Hands-on experience selling Chemistry, Manufacturing, and Controls (CMC) solutions.
• Post-Approval Lifecycle Management: Familiarity with regulatory variations, renewals, compliance reporting, and overall lifecycle management.

Career Advancement & Vision

• Executive Growth Path: Clear opportunity to evolve into a Chief Commercial Officer (CCO) role.
• Builder’s Opportunity: Ideal for someone seeking to actively shape and grow a company, not just manage what’s already in place.

Experience & Track Record

• Relevant Industry Tenure: 6-10 years in business development or commercial roles within life sciences, regulatory, or related CRO/CDMO services.
• Proven Impact: Demonstrated ability to drive revenue and maintain strong relationships within the pharma/biotech regulatory space.